Amedeo's Top 20

Amedeo Smart

Independent Medical Education

05 March 2018

Multidisciplinary Journal Club

  1. Bines JE, At Thobari J, Satria CD, Handley A, et al.
    Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth.
    N Engl J Med 2018;378:719-730.

  1. Budd AP, Wentworth DE, Blanton L, Elal AIA, et al.
    Update: Influenza Activity - United States, October 1, 2017-February 3, 2018.
    MMWR Morb Mortal Wkly Rep 2018;67:169-179.

  2. Shendure J, Balasubramanian S, Church GM, Gilbert W, et al.
    DNA sequencing at 40: past, present and future.
    Nature 2017;550:345-353.

  3. Nielsen PB, Skjoth F, Overvad TF, Larsen TB, et al.
    Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc?
    Circulation 2018;137:832-840.

  4. Kojic EM, Conley L, Bush T, Cu-Uvin S, et al.
    Prevalence and Incidence of Anal and Cervical High-Risk Human Papillomavirus (HPV) Types covered by Current HPV Vaccines among HIV-Infected Women in the Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy %2
    J Infect Dis 2018.

  1. Friedman DJ, Parzynski CS, Heist EK, Russo AM, et al.
    Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: A Report from the National Cardiovascular Data Registry.
    Circulation 2018.

  2. Krieger EM, Drager LF, Giorgi DMA, Pereira AC, et al.
    Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment).
    Hypertension 2018.

  3. Pham LV, Ramirez S, Gottwein JM, Fahnoe U, et al.
    HCV Genotype 6a Escape from and Resistance to Velpatasvir, Pibrentasvir, and Sofosbuvir in Robust Infectious Cell Culture Models.
    Gastroenterology 2018.

  4. Jeon J, Du M, Schoen RE, Hoffmeister M, et al.
    Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors.
    Gastroenterology 2018.

  5. Asrani SK, Saracino G, O'Leary JG, Gonzales S, et al.
    Recipient characteristics and morbidity and mortality after liver transplantation.
    J Hepatol 2018.

  1. Trebicka J.
    Emergency TIPS in a Child-Pugh B patient: When does the window of opportunity open and close?
    J Hepatol 2017;66:442-450.

  2. Heinemann L, Freckmann G, Ehrmann D, Faber-Heinemann G, et al.
    Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.
    Lancet 2018.

  3. Buendia JR, Li Y, Hu FB, Cabral HJ, et al.
    Regular Yogurt Intake and Risk of Cardiovascular Disease Among Hypertensive Adults.
    Am J Hypertens 2018.

  4. Ji RR, Nackley A, Huh Y, Terrando N, et al.
    Neuroinflammation and Central Sensitization in Chronic and Widespread Pain.
    Anesthesiology 2018.

  5. Ott JJ, Horn J, Krause G, Mikolajczyk RT, et al.
    Time trends of chronic HBV infection over prior decades - A global analysis.
    J Hepatol 2017;66:48-54.

  1. Chen H, Shen F, Sherban A, Nocon A, et al.
    DEPTOR Suppresses Lipogenesis and Ameliorates Hepatic Steatosis and Acute-on-Chronic Liver Injury in Alcoholic Liver Disease.
    Hepatology 2018.

  2. Chaparro M, Verreth A, Lobaton T, Gravito-Soares E, et al.
    Long-Term Safety of In Utero Exposure to Anti-TNFalpha Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.
    Am J Gastroenterol 2018.

  3. Ketteler M, Block GA, Evenepoel P, Fukagawa M, et al.
    Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update.
    Ann Intern Med 2018.

  4. Spina V, Bruscaggin A, Cuccaro A, Martini M, et al.
    Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma.
    Blood 2018.

  5. Hashida R, Kawaguchi T, Bekki M, Omoto M, et al.
    Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review.
    J Hepatol 2017;66:142-152.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016